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ABSTRACT
Zebrafish transgenesis is increasingly popular owing to the optical
transparency and external development of embryos, which provide a
scalable vertebrate model for in vivo experimentation. The ability to
express transgenes in a tightly controlled spatio-temporal pattern is an
important prerequisite for exploitation of zebrafish in a wide range of
biomedical applications. However, conventional transgenesis methods
are plagued by position effects: the regulatory environment of genomic
integration sites leads to variation of expression patterns of transgenes
driven by engineered cis-regulatory modules. This limitation represents
a bottleneck when studying the precise function of cis-regulatory
modules and their subtle variants or when various effector proteins are
to be expressed for labelling and manipulation of defined sets of cells.
Here, we provide evidence for the efficient elimination of variability of
position effects by developing a PhiC31 integrase-based targeting
method. To detect targeted integration events, a simple phenotype
scoring of colour change in the lens of larvae is used. We compared
PhiC31-based integration and Tol2 transgenesis in the analysis of the
activity of a novel conserved enhancer from the developmentally
regulated neural-specific esrrga gene. Reporter expression was highly
variable among independent lines generated with Tol2, whereas all
lines generated with PhiC31 into a single integration site displayed
nearly identical, enhancer-specific reporter expression in brain nuclei.
Moreover, we demonstrate that a modified integrase system can also
be used for the detection of enhancer activity in transient transgenesis.
These results demonstrate the power of the PhiC31-based transgene
integration for the annotation and fine analysis of transcriptional
regulatory elements and it promises to be a generally desirable tool for
a range of applications, which rely on highly reproducible patterns of
transgene activity in zebrafish.
KEY WORDS: Zebrafish, Integrase, Transgenesis, Tol2, Enhancer,
Position effects
INTRODUCTION
Transgenesis is one of the fastest growing technologies in the
zebrafish model system. ZFIN, the Zebrafish Model Organism
Database (Bradford et al., 2011), lists 10,867 transgenic zebrafish
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lines. Transgenic zebrafish are produced for a variety of reasons, from
in vivo labelling of cells and tissues to tissue-specific cell ablation,
analysis of gene function, protein dynamics and localisation,
generation of disease models through mis-expression of disease-
associated genes, or manipulation of gene activities for developmental
and physiological analysis (e.g. Gilmour et al., 2002; Langenau et al.,
2005; Curado et al., 2008; Wyart et al., 2009; Hans et al., 2011).
With the publication of the ENCODE project and the discovery
of the pervasiveness of predicted non-coding cis-regulatory modules
(CRMs) in vertebrate genomes, emphasis is put on the functional
validation of these computationally and biochemically predicted
elements. Small laboratory fish models, such as zebrafish and
medaka, with external development of optically transparent embryos
and relatively easy transgenesis stand to make a major contribution
to this area (Rada-Iglesias et al., 2011; Bernstein et al., 2012) and
can meet the high-throughput capabilities demanded by the vast
genomics data generated by next generation sequencing
technologies (e.g. Gehrig et al., 2009). For functional analysis,
predicted CRMs are often placed in front of a minimal promoter
driving fluorescent protein expression. The construct is injected into
zebrafish embryos and expression of the fluorescent reporter is used
as a readout of CRM activity (reviewed by Ishibashi et al., 2013).
In most cases, the CRM-fluorescent reporter cassette is placed into
a Tol2 transposon vector to facilitate genomic integration of the
transgene (Kawakami, 2004; Fisher et al., 2006; Kwan et al., 2007).
However, the regulatory environment of the locus of the transgene
integration may influence the expression of the transgenic reporter,
leading to substantial variability of reporter expression through
ectopic enhancement or silencing. These observations are
collectively termed position effects (Jaenisch et al., 1981; Wilson et
al., 1990; Rossant et al., 2011). Throughout this manuscript we use
the term ‘variability of position effects’, to describe expression
variation among transgenic lines with different integration sites to
distinguish from ‘position effect variegation’ (PEV), a phenomenon
characterised by variable changes (silencing) of a transgene among
cells of an organism (Schotta et al., 2003). Variability of position
effects are utilised in enhancer trapping, or enhancer detection, in
which the regulatory landscape of the genome is probed by a weak
expression cassette (Wilson et al., 1990; Balciunas et al., 2004;
Parinov et al., 2004; Ellingsen et al., 2005; Davison et al., 2007;
Scott et al., 2007; Asakawa et al., 2008). In most, if not all, other
applications, where predesigned and controlled expression of
transgenes is intended, random transgene integration and position
effects are major obstacles. Such negative observations are often
quoted in scientific meetings and discussions but are seldom
published. We have found that 29 out of 30 lines generated with
eight constructs using Tol2 transgenesis contained substantial
variation of gene expression among lines with the same construct,
probably caused by position effects (Y.H. and F.M., unpublished).
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Furthermore, flanking an expression cassette by insulator elements
does not seem to reduce position effects (Grajevskaja et al., 2013).
Taken together, the consequence of variable position effects is that
often a large number of transgenic lines have to be generated with a
single DNA construct to be able to obtain information on tissue-
specific activity or to conclude correctly on the function of a tested
cis-regulatory element.
Site-specific transgene integration using PhiC31 integrase has the
potential to limit variability of position effects, leading to much
faster and more precise analysis of putative CRMs in the zebrafish
model system. Thus, site-specific integration would enable more
efficient and high-throughput analysis of putative CRMs with
increased reproducibility. Importantly, a robust targeted integration
system would aid in the exploitation of the transgenic zebrafish
model in the functional analysis of single nucleotide polymorphism
(SNP) variants in CRMs identified in large numbers by recent
genome-wide disease association studies (Ragvin et al., 2010;
Maurano et al., 2012), particularly in those cases in which the SNP
was expected to cause only subtle, quantitative changes in gene
expression (e.g. Gaulton et al., 2010).
Several methods for site-specific integration of transgenes may be
applied in zebrafish. Cre and Flp recombinases have been used for
site-specific integration of transgenes in animal models (reviewed
by Branda and Dymecki, 2004), but transgene integration potential
of these recombinases has not yet been tested in zebrafish. A
transcription activator-like effector nuclease (TALEN)-based method
for site-specific transgene integration has been described but suffers
from very low efficiency of germline transmission (Zu et al., 2013).
Based on successful application in the mouse and especially the
fruit fly (Olivares et al., 2002; Groth et al., 2004; Venken and Bellen,
2012), we decided to develop a PhiC31-based method for analysis
of enhancer activity in zebrafish. The natural function of PhiC31
integrase is to facilitate the integration of the phage genome into the
bacterial host genome (Kuhstoss and Rao, 1991). PhiC31 integrase
binds to two recognition sites, attP and attB, and exchanges DNA
strands between them (Smith et al., 2004). Lister (Lister, 2010)
demonstrated that PhiC31 integrase can facilitate intramolecular
excision of a DNA sequence flanked by attP/attB sites in zebrafish
(Lister, 2010; Lister, 2011). More recently, targeted integration of a
transgene by PhiC31-mediated cassette exchange and insertion of
circular plasmid were demonstrated in the genome of zebrafish (Hu
et al., 2011; Mosimann et al., 2013).
We have developed a simple phenotype-based strategy using eye
colour change to monitor site-specific integration of a transgene into
the zebrafish genome. We have reproducibly achieved an ~10%
germline transmission rate with site-specific transgenesis using
PhiC31. Compared with Tol2-mediated random integration, PhiC31-
mediated site-specific integration resulted in reduced variability and
aided in the detection of the tissue-specific activity of a novel neural
enhancer from the locus of the esrrga gene. A modified phenotyping
strategy was also developed to detect enhancer function by the
analysis of targeted, mosaic transgene activity in microinjected
founder embryos.
RESULTS
In vivo detection system for targeted integration of reporter
constructs in zebrafish
We have adapted a site-specific integration system with PhiC31
integrase consisting of two components: ‘recipient transgenic lines’
containing docking attP site(s) in the genome, and targeting plasmids
containing attB site(s) (Thorpe and Smith, 1998). In mouse and
human cells, integrations were observed to also occur into ‘pseudo’
attP sites, i.e. endogenous sequences with similarity to the attP site
(reviewed by Keravala and Calos, 2008). To facilitate screening for
desired site-specific integrations, we designed a phenotypic selection
based on fluorescent reporter colour change in the lens (Fig. 1A).
Our recipient transgenic lines [Tg(Xla.crygc:attP-GFP)] contain a
lens-specific crygc:GFP cassette (Davidson et al., 2003) with an attP
site placed between the lens-specific Xenopus laevis gamma-
crystalline promoter and GFP (henceforth crygc:attP-GFP for
brevity). To monitor site-specific integration, our targeting vectors
contain an attB site followed by a red fluorescent reporter (either
mRFP or mCherry). Site-specific integration into crygc:attP-GFP
docking site is expected to produce a crygc:attR-Red recombinant
site, which can be scored by red fluorescence in the lens. Random
integration of this attB-Red targeting vector into the genome is
extremely unlikely to result in RFP expression.
Two different targeting site vectors were constructed: a Tol2-based
vector pTol2/Xla.crygc:attP-GFP (pDB896) containing miniTol2
arms and a Sleeping Beauty-based vector pT2/Xla.crygc:attP-GFP
(pKW1) (Fig. 1A). Docking site vectors were co-injected into
zebrafish embryos with in vitro-transcribed Tol2 (Balciunas et al.,
2006) or SB100X (Mátés et al., 2009) mRNA. Injected embryos
positive for lens GFP fluorescence at 3 dpf were raised to adulthood.
Founder adults were crossed and their embryos were screened for
lens GFP fluorescence at 3-5 days post-fertilisation (dpf). GFP-
positive embryos were raised to establish the F1 generation. Five
different founders produced GFP-positive progeny in Tol2-mediated
transgenesis and three different founders produced GFP-positive
embryos for SB-mediated transgenesis (supplementary material
Table S1). We molecularly characterised the five genomic loci
harbouring the docking site by inverse PCR and Southern blotting
(supplementary material Fig. S1 and Table S1) and confirmed
linkage of the identified integration event with GFP fluorescence
(tpl102, tpl103, tpl104, uobL6 and uobL12). The docking loci
represent a variety of genomic landscapes: 700-kb intergenic region
100 kb away from nearest gene (uobL6), middle of a 100-kb
intergenic region (uobL12), 5-kb intergenic region with two
divergently transcribed genes (tpl102), and within a gene (tpl103
and tpl104) (supplementary material Table S1 and Fig. S2). Third
generation homozygous individuals of recipient lines uobL6 and
uobL12 have been outcrossed and resulting offspring were raised to
adulthood without notable reduction in fecundity and viability,
whereas incrosses of the lines tpl102, tpl103 and tpl104 did not lead
to developmental abnormalities in their offspring up to 6 dpf,
arguing against mutagenicity of the docking site transgenes (data not
shown).
High frequency of PhiC31-mediated targeting detected by
lens reporter activity
Next, we investigated whether we can visualise PhiC31 integrase-
mediated insertion of a targeting plasmid containing an attB site into
an attP site in zebrafish using an in vivo detection system of reporter
activity in the lens. In vitro-transcribed PhiC31 mRNA was injected
along with attB-Red constructs into one-cell zebrafish embryos from
the Tol2-based transgenic recipient line Tg(Xla.crygc:attP-GFP).
When transgenic embryos containing the docking site were co-
injected with PhiC31 mRNA and the targeting construct pJET-attB-
mCherry, up to 66.7% of normal developing larvae were RFP-
positive in one or both lenses (n=258, Fig. 1B). By contrast, 0%
(n=302) of recipient transgenic embryos injected with targeting
vector DNA without PhiC31 mRNA were RFP-positive in the lens,
indicating that the eye colour change was due to integrase-mediated
recombination events at docking sites in the recipient transgenic








locus. We confirmed integrase-dependent transgene integration by
PCR amplification and sequencing of the attL and attR sites, which
arise by recombination of attP and attB sites (Fig. 1A,C).
In accordance with previously published observations (Hu et al.,
2011), we observed that PhiC31 RNA in vitro transcribed from a
pT3TS (Hyatt and Ekker, 1999) or pCS2+ based vectors was
highly toxic to zebrafish embryos (supplementary material Table
S2). A significant percentage of abnormal/dead embryos was
observed using as little as 15 pg of integrase RNA (supplementary
material Table S2). It was recently demonstrated that addition of
nanos1 3′ UTR to PhiC31 mRNA leads to improved embryo
survival and germline transmission of recombination events in
zebrafish (Hu et al., 2011). Indeed, we observed improved survival
upon injection of PhiC31-nos1-3′UTR compared with PhiC31
without nanos1 3′ UTR (supplementary material Table S2).
Injection of PhiC31-nos1-3′UTR mRNA did not substantially
reduce the viability of primordial germ cells (supplementary
material Table S2). However, co-injection of PhiC31-nos1-3′UTR
into SB-based recipient lines resulted in varying percentage of lens
RFP-positive embryos. We observed 48% (33/69), 14% (6/43) and
36% (9/25) RFP-positive embryos upon injection into tpl102,
tpl103 and tpl104, respectively (data not shown). RFP-positive
embryos were raised to adulthood, outcrossed and resulting
embryos were screened for lens RFP. Rates of site-specific
germline transgenesis are ~10%, and they slightly varied between
experiments using different docking loci and different types of
integrase RNA (supplementary material Table S3).
Identification of enhancer-specific expression features
obtained in various genomic loci
To test if site-specific integration would help in reducing the
variability of position effects in experiments aiming to characterise
enhancer-driven tissue-specific reporter gene activity, we analysed
reporter activity driven by a putative highly conserved enhancer after
integration into the genome either by Tol2 or by PhiC31 integrase. In
order to select candidate enhancers, we have identified highly
conserved syntenic sequences with >80% sequence identity between
the zebrafish and human genome (see Materials and Methods). They
do not overlap any known exon of annotated coding or noncoding
genes. We choose EL161 for this study, which resides in the last intron
of the esrrga gene in zebrafish (supplementary material Fig. S3).
Based on the conserved synteny and conservation around the esrrga
gene, we postulated that EL161 may regulate esrrga expression
(Bardet et al., 2004; Thisse et al., 2004). In a preliminary study,
EL161, when linked to the krt4 gene minimal promoter with minimal
transcriptional activity (Gehrig et al., 2009) was able to activate
reporter transgenes in the brain; however, the expression was highly
variable due to position effects (our unpublished data).
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Fig. 1. In vivo detection system for targeted integration of reporter constructs in zebrafish. (A) Schematic of PhiC31 targeted integration system.
Transgenic embryos containing an attP docking site have a green lens due to the gamma-crystalline promoter driving a GFP reporter. ITR labels recognition
sequences of either Tol2 or Sleeping beauty transposases used in generating the recipient transgenic lines with docking site. Injection of a circular plasmid with
attB and a red reporter (targeting vector) into recipient line eggs leads to eye colour change upon PhiC31-targeted integration in larvae. (B) Detection of eye
colour change upon PhiC31-mediated integration in the transgenic recipient Tg(Xla.crygc:attP-GFP)uobL6 line. Top row shows a transgenic larva with PhiC31-
mediated recombination of the attB-mCherry cassette into the attP-GFP docking site. Bottom row shows transgenic sibling from the recipient line without
targeted integration. Side views on cranial end of 5 dpf larvae with anterior to the left. Scale bar: 100 μm. Arrows indicate reporter expression in the lens.
(C) Sequence of the tpl102 recipient docking site with germline integration of targeting construct tnnT2:attB-mRFP. Sequence shows the attR site in the









The Tol2/EL161-krt4:YFP cassette containing the EL161
element was then used with both Tol2- and PhiC31-mediated
transgenesis. Tol2-mediated transgenesis is expected to integrate
only the Tol2/EL161-krt4:YFP cassette into the genome (Fig. 2A,
top), whereas PhiC31-mediated transgenesis integrates the whole
vector containing Tol2/EL161-krt4:YFP and attB:mCherry (Fig.
2B, top). We screened F1 embryos of 20 founders injected with
Tol2 by fluorescence microscopy, and recovered ten different
YFP expression patterns, suggesting multiple integration sites
and that Tol2/EL161-krt4:YFP is highly susceptible to position
effects (Fig. 2A). We screened the offspring of all 29 adult
founders from uobL6 and uobL12 injected with PhiC31 integrase
and showing eye colour change during larval development. Four
of these founders gave progeny with red lenses together with
YFP expression pattern, indicating site-specific integration events
(Fig. 2B; supplementary material Tables S3, S4). Notably, the
three founders with targeted integration into the uobL6 line
showed remarkable similarity in their expression patterns, in
contrast to Tol2-mediated transgene integrations, which were
characterised by widely varying patterns (Fig. 2; supplementary
material Table S5).
To evaluate the specific reporter activity driven by EL161
element and to dissect enhancer-driven activity from position
effects, we have identified distinct expression domains and
analysed the frequency of their occurrence in targeted and random
transgene integration loci. We have identified a total of 20 domains
of activity labelled 1-20 (Figs 2, 3; supplementary material Figs
S4, S5). The PhiC31 integrase-mediated expression activity was
present in seven distinguishable expression domains in the neural
tube (Fig. 3). Six out of seven expression domains were shared
between the three lines with targeting events in the same L6
docking site and only one additional domain (Domain 7) registered
in one line indicating mild variation (Fig. 3B). By contrast, Tol2
lines showed a total of 21 expression domains with a variation
between seven and 12 domains per pattern, which included a
variety of tissues such as somatic muscle, pectoral fins and heart
besides neural tube activity (Fig. 3B). This result indicates that
integrase-mediated targeting of a single locus (in uobL6) led to
reduced variability of expression patterns induced by a neural
enhancer among transgenic lines.
The expression domains 1-6 were shared among uobL6 and
uobL12 integration loci and were present in eight out of ten Tol2-
mediated transgene loci, which together suggest autonomous
enhancer activity in these neural domains. This result demonstrates
that the shared expression patterns are unlikely to be due to
position effects at the uobL6 locus and are autonomous property
of the targeting transgene (Fig. 3A,B). Notably, these six shared
expression domains, including epiphysis, diencephalic and
hindbrain nuclei and tegmentum, overlap with expression domains
of the esrrga gene (supplementary material Fig. S6) (also see
www.zfin.org) (Bardet et al., 2004), suggesting that EL161 may
contribute to the activity of esrrga in these neural subdomains.
Low level of variability was still observed in these transgenic
lines, at least in part explained by variation in focal planes of
imaging as well as by potential differences in developmental stage
of the individuals imaged. For stage-dependent variation of
transgene activity, see supplementary material Fig. S7. The
variability of expression patterns among PhiC31-mediated targeted
integrants was significantly lower than those found among Tol2-
mediated transgene integrants (likelihood ratio=15.0, DF=1,
P=0.0001). Taken together, the low variability of transgene activity
observed in PhiC31-targeted integration events demonstrate
superior reproducibility and robustness of enhancer-driven
expression patterns compared with that obtained by transposase-
mediated integration.
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Fig. 2. Variability of position effects on reporter activity is sharply
reduced among PhiC31 integrase-mediated transgenic lines compared
with Tol2 transgenesis. (A) Schematic of the pTol2/EL161-krt4:Venus
construct injected with Tol2 transposase mRNA. Below are examples of
expression patterns of transgenic F1 larvae (3 dpf). TP indicates Tol2-
mediated expression patterns. Numbers refer to domains of Venus
expression activity (listed in Fig. 3B). (B) Schematic indicates the
recombination of the targeting plasmid pattB-mCherry,Tol2/EL161-krt4:Venus
into the attP docking site of the transgenic recipient line Tg(Xla.crygc:attP-
GFP)uobL6. Larvae from three different founders (IF1, IF2, IF8) targeted with
PhiC31 integrase are shown. Venus expression domains are labelled as in
Fig. 3B. Lens activity driven by mCherry (arrowheads in bottom row)
demonstrates PhiC31-mediated integration. Insert in bottom right shows
brightfield image of the head region. Arrows labelled ‘ysl’ in red channel
indicate auto-fluorescence of the yolk syncytial layer. Dorsal views of larvae








Transient transgenesis strategy for rapid evaluation of
enhancer activity upon PhiC31-mediated targeting
Transient transgenic zebrafish with mosaic reporter activity have often
been used for the analysis of enhancer function because they allows
high-throughput analysis of cis-regulatory elements (Gehrig et al.,
2009; Rada-Iglesias et al., 2011). Because transient transgenesis is
likely to suffer from variability, we tested whether the PhiC31-based
integration strategy could also be applied for analysis of enhancer
activity in mosaic transgenic embryos. To ensure that only targeted
integration events are detected by reporter activity, we have designed
a modified targeting strategy (Fig. 4), whereby an attB site is cloned
adjacent to an enhancer-promoter combination, and can only lead to
GFP activity driven by these cis-regulatory elements when PhiC31
integrase targets the donor construct upstream to the GFP in the
recipient line (Fig. 4A). A set of well-characterised embryonic
midline-specific enhancers, ar-A, B and C in introns 1 and 2 and ar-
D in the upstream sequence of the promoter from the sonic hedgehog
(shh) gene (Müller et al., 1999; Hadzhiev et al., 2007), were joined to
the attB with or without mCherry reporter. These donor vectors were
injected with PhiC31o-nos1-3′UTR integrase mRNA into embryos of
incross of uobL12 recipient line, in which the multicopy docking site
maximised the probability of targeting by PhiC31 integrase.
Expression of gfp in tissues [floor plate, ventral brain, retina
(Shkumatava et al., 2004)] in which shh enhancers are active was
detected by whole-mount in situ hybridisation in 52.0% (n=25) and
46.2% (n=91) of donor construct-injected embryos with or without
mCherry, respectively at high-pec stage with green lens. No embryos
without lens reporter (n=5 and n=23, respectively) showed any gfp
expression (Fig. 4B,C; supplementary material Table S6). These
results indicate that gfp expression driven by shh regulatory elements
was due to landing at the docking site. Expression was highly specific
to the shh pattern, only 15.4% (n=13) and 6.3% (n=16) of analysed
embryos with shh pattern showing ectopic gfp activity in a small
number of cells (data not shown) and no embryos showing ectopic
activity without shh pattern, respectively. The activity of the GFP
reporter protein was also detected by fluorescence albeit at lower
frequency, 3.8% (n=53) and 4.4% (n=91) of lens GFP-positive
embryos [3.8% (n=53) and 4.4%, (n=91), respectively], compared
with 0% (n=23) of lens GFP-negative embryos (Fig. 4C). These
results together demonstrate a proof of principle application for
enhancer testing in mosaic transgenic zebrafish embryos using PhiC31
integrase-mediated transgenesis.
DISCUSSION
We tested the ability of PhiC31 integrase to site-specifically
integrate transgenes into the zebrafish genome. We devised a simple
phenotypic screening strategy based on change of lens fluorescence,
and demonstrated germline transmission of site-specific integration
rates in >10% of injected founders using different targeting
transgenes, different recipient lines and two different versions of in
vitro transcribed PhiC31 transposase. The simple phenotyping tool
based on lens colour change provides an easily detectable measure
719
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Fig. 3. Reproducible Venus expression patterns upon
targeted integration of EL161 enhancer construct
demonstrate cis-regulatory function in the brain. (A) Brain-
specific enhancer effect of a transgene inserted in different
integration sites. Domains of Venus activity are specified in B.
Dorsal (top) and lateral (bottom) views of the head of 3 dpf F1
transgenic larvae. Scale bar: 100 μm. (B) Domains of Venus
reporter expression and their distribution among targeted (PhiC31
integrase) and randomly (Tol2 transposase) transgenic lines. IF,
integrase-injected founders; IP, integrase-mediated expression
patterns; TF, Tol2-injected founders; TP, Tol2-mediated
expression patterns. Blue depicts expression domains
overlapping with esrrga activity, whereas red colour indicates









of targeted integration events, yet is restricted to the lens with little
interference with imaging anatomical features commonly studied by
reporter expression-based assays. We chose the crystalline promoter
for screening integrants because it is representative of a specialised
class of promoters characteristic of highly active tissue-specific
genes with no interaction with long-range enhancers (reviewed by
Lenhard et al., 2012). As expected, no interference was detected
from the crystallin promoter on the tissue-specific enhancer
construct inserted in the vicinity.
We have demonstrated a reproducible expression pattern driven
by a predicted transcriptional enhancer using targeted integration of
an expression cassette. The observed expression domains appeared
to match broadly with expected activity of esrrga, the predicted
target gene for the enhancer. Given that enhancers can act at
distances as far as 1 Mb (reviewed by Krivega and Dean, 2012),
unambiguous identification of the target gene(s) remains
challenging. Nevertheless, we were able to identify several esrrga
expression domains with reproducible activity, which were
attributable to the enhancer in independent genomic integration sites.
Tol2 transgenics also showed several of the enhancer-specific
patterns but were mostly coupled to a variety of additional ectopic
patterns. It is unlikely that the additional patterns are due to Tol2
sequences as the PhiC31 donor vector also included them.
uobL6 appeared to be an excellent landing site for the analysis of
the EL161 enhancer; however, this may not be the case for other
CRMs. It is expected that genomic context and enhancer promoter
interaction specificity (Gehrig et al., 2009) will affect different
CRMs to varying degrees. To identify optimal sites for a broad
range of CRMs, more landing sites will need to be generated and
evaluated in the future. Towards this long-term goal we have
established and molecularly characterised five different recipient
lines. The five ‘docking’ loci cover a variety of locations with
respect to potential position effects, including intragenic as well as
large (0.7 and 0.1 Mb) intergenic regions, and provide a variety of
genomic contexts for future analyses of position effects. Many
pseudo-att sites may exist in the genome (Hu et al., 2013).
Integration of the donor plasmid into a pseudo-att site is expected to
yield YFP fluorescence in the absence of RFP fluorescence. We
observed 100% concordance between red lens colour and YFP
expression pattern, which indicates that such non-specific events are
extremely rare, consistent with a recent publication by Mosimann
and colleagues (Mosimann et al., 2013).
We chose insertion of full donor constructs as opposed to the
previously published strategy of cassette exchange (Hu et al., 2011).
Cassette replacement has the advantage that the vector backbone is
not integrated, eliminating the potential impact of bacterial vector
backbone on transgene expression. However, the advantage of the
insertion strategy applied here lies in the simplicity of the transgene
design and the fact that there appears to be no size limit for the
sequence to be integrated (Venken et al., 2009), making it potentially
applicable for analysis of large vectors such as bacterial artificial
chromosomes to test regulatory function of super-enhancers, CRMs
acting at large distance and multiple CRMs acting synergistically
(Kikuta et al., 2007; White et al., 2008).
In accordance with previously published work, we find that wild-
type PhiC31 integrase RNA is toxic to zebrafish embryos (Hu et al.,
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Fig. 4. Transient transgenesis strategy for rapid
evaluation of enhancer activity upon PhiC31-mediated
targeting. (A) Schematic of PhiC31-targeted integration
system, designed for cis-regulatory element analyses in
transient transgenic embryos. ‘-2.4 shh’, 2.4 kb upstream
region of shh gene; ‘shhABC’, shh complete introns 1 and
2, with ar-A, ar-B, ar-C enhancers (Müller et al., 1999;
Ertzer et al., 2007). (B) Detection of reporter activity in
embryos injected with construct containing the shh cis-
regulatory elements by in situ hybridisation (B) and
fluorescence microscopy (C). Arrows indicate activity in
shh expression domains, resulting from successful
integration of the shh cis-regulatory cassette in to the attP
site of uobL12, whereas arrowheads indicate the activity of









2011). Application of PhiC31-nos1-3′UTR resulted in substantially
increased embryo survival and somewhat reduced activity in
somatic tissues, similarly to previously published work (Hu et al.,
2011). Interestingly, application of PhiC31-nos1-3′UTR did not
result in a significant increase in germline transmission of targeting
events. It is also reasonable to expect that different recipient loci
may have different accessibility for PhiC31-mediated integration. In
this light, the fact that our site-specific transgenesis rate was
reproducible using different recipient lines, different targeting
vectors and two different integrase expression vectors is very
encouraging for future reproducibility of this method.
We have demonstrated in a proof of principle experiment that a
PhiC31 integrase-mediated targeting strategy can also aid in
generating transient transgenic embryos with reproducible patterns
of mosaic expression of transgene reporter driven by tissue-specific
cis-regulatory elements. Transient transgenics are immensely useful
for fast and high-throughput analysis of a large number of potential
cis-regulatory modules (Woolfe et al., 2005; Gehrig et al., 2009;
Bernstein et al., 2012). The targeted integration system described
herein will improve the reliability and thus the utility of transient
transgenesis-based enhancer validation data. The targeting strategy
presented here has the advantage of unambiguous identification of
integration events by tissue-specific activity of the GFP reporter.
However, it is suboptimal for fluorescence microscopy potentially
owing to reduced translational efficiency of the reporter when
preceded by an attR site. Future experiments will be required to test
alternative integration strategies that do not impact on translational
efficiency (e.g. a system whereby reconstitution of mRNA splicing
occurs upon targeted integration) and/or test potentially more
sensitive, enzymatic reporters, such as lacZ.
It should be noted that reproducibility of transgene expression
offered by site-specific integration has a much broader range of
potential application than functional characterisation of CRMs. It
will enable investigators to first integrate a cassette containing a
fluorescent reporter into a specific locus and determine precise
spatiotemporal expression pattern of the transgene. Subsequently, a
cassette in which the fluorescent reporter has been replaced with an
effector transgene (e.g. Cre recombinase, calcium channel
rhodopsin, calcium sensor, nitroreductase or dominant-negative
signalling protein) integrated into the very same locus will provide
highly reproducible spatiotemporal expression activity. Furthermore,
site-specific integration will simplify comparison of phenotypic
effects of several different transgenes expressed in the same
spatiotemporal pattern at comparable levels.
During the revision of this manuscript, a similar report has been
published showing enhancer testing with PhiC31 integrase-mediated
integration in the medaka (Oryzias latipes), signifying the
importance of this technology in vertebrate model organisms
(Kirchmaier et al., 2013).
MATERIALS AND METHODS
Generation of plasmid vectors for PhiC31-mediated integration
system in zebrafish
We generated two recipient vectors with an attP docking site for the PhiC31
integrase. pTol2/Xla.crygc:attP-GFP (pDB896) vector contains miniTol2
arms (Balciunas et al., 2006), ~390 bp of the X. laevis gamma-crystallin
promoter (Davidson et al., 2003), an 83 bp attP integrase recognition site
(Thorpe and Smith, 1998), GFP coding sequence and a SV40 pA tail.
pT2/Xla.crygc:attP-GFP (pKW1) is identical to the Sleeping Beauty vector
pT2/gCry:GFP (pDB387) (Davidson et al., 2003), but has an 83 bp attP site
inserted between BamHI and KpnI sites. The targeting vector pJET-attB-
mCherry was constructed by joining an 84 bp attB sequence (Thorpe and
Smith, 1998) to the mCherry coding sequence with polyA tail by PCR. This
PCR product was then cloned into pJET1.2 using a blunt-ended cloning kit
(Thermo Scientific). The targeting vector tnnT2(3.2)-attB:mRFP contains a
heart-specific 3.2 kb tnnT2 promoter followed by 83 nucleotide attB site and
monomeric RFP (mRFP) (Campbell et al., 2002) for potential phenotypic
screening of heart RFP activity indicating random or illegitimate integration
events). The pCS2+PhiC31 plasmid was generated by amplifying PhiC31
coding sequence from plasmid pPhiC31o (Addgene) using the following
primers: F: 5′-AAAAGGATCCATGGATACCTACGCCGGAG- 3′; R: 5′-
AAATTCTCGAGTCACACTTTCCGCTTTTTCTTAG-3′. This sequence
was then cloned into pCS2+ vector using BamHI and XhoI sites.
pCS2+PhiC31 plasmid was linearised with NotI (New England Biolabs) and
this product was used to synthesise PhiC31 mRNA using the in vitro
transcription kit mMESSAGE mMACHINE (Ambion), according to the
manufacturer’s instructions. The pT3TS-PhiC31 (pRG3) plasmid contains
an integrase open reading frame from pCS2+PhiC31 cloned between BglII
and SpeI sites of in vitro transcription vector pT3TS (Hyatt and Ekker,
1999). The plasmid was linearised using XbaI and in vitro transcribed using
mMESSAGE mMACHINE (Ambion) in vitro transcription kit and T3 RNA
polymerase. After RNA synthesis and DNase digestion, RNA was purified
using RNeasy MiniElute RNA purification kit (Qiagen). pCS2+PhiC31o-
nos1-3′UTR plasmid was a kind gift from Dr Shannon Fisher (University of
Pennsylvania, PA, USA). The mRNA for microinjection was made as
described by Hu et al. (Hu et al., 2011), except that after synthesis and
DNase digestion, RNA was purified using RNeasy MiniElute RNA
purification kit (Qiagen). Constructs described in this article will be made
available through Addgene.
Identification conservation analysis and cloning of esrrga
enhancer
The zebrafish (Zv9) and human (GRCh37) repeated masked version of the
genomes were downloaded from the Ensembl FTP site (Flicek et al., 2013).
The Ensembl gene annotations (coordinates of the genes and the exons and
homology relationships) were downloaded from BioMart using R and the
Bioconductor package BiomaRt (ensembl mart version 60) (Durinck et al.,
2005; Durinck et al., 2009). The zebrafish genome was aligned against the
human genome using blastn (Camacho et al., 2009) from the blast+ suite
(version 2.2.24) with a word_size parameter of 50 bp. The resulting
conserved regions were mapped according to the overlapping/flanking
genes. Sixteen conserved elements showing the following features were
considered: (1) minimum 500 bp length, (2) minimum 80% identity, (3)
overlapping and/or directly flanking at least one pair of homologous genes
between zebrafish and human and (4) presence of the element in the same
genomic context (intronic or intergenic) in the two species. The 794 bp
conserved element EL161 from the last intron of the esrrga gene was
selected from the list and amplified by PCR from zebrafish genomic DNA
using the oligos 5′-CATCCTAAATTTGGTGTCCTCTCTG-3′ (forward)
and 5′-TGCGTCAACAAGATGAGATGAAC-3′ (reverse) and cloned
upstream of the minimal promoter from the keratin 4 (krt4) gene and a
Venus reporter gene (Gehrig et al., 2009) using Gateway Multisite System
(Urasaki et al., 2006; Roure et al., 2007) resulting in the vector
pTol2/EL161-krt4:Venus. For PhiC31 integrase-mediated experiments, the
attB-mCherry cassette from pJET-attB-mCherry vector was cloned into the
NotI site of pTol2/EL161-krt4:Venus construct using PCR In-Fusion System
(Clontech), according to the manufacturer’s instructions. The primers used
for amplifying attB-mCherry cassette were: F: 5′-AGTTCTAGAG -
CGGCCGCATTGACGGTCTCGAAGCCG-3′ and R: 5′-ACCGCGGTGG -
C GGCCGCAAAAAACCTCCCACACCTCCC-3′. The resulting vector was
named pattB-mCherry,Tol2/EL161-krt4:Venus.
Production and microinjection of zebrafish fertilised eggs
Fertilised zebrafish eggs were generated by natural crossings. The zygote
stage embryos were injected with either with 3 nl of water solution
containing 8.3 ng/μl DNA and 8.3 ng/μl of PhiC31 integrase transcribed
from pT3TS or with 15 ng/μl of DNA and 15 ng/μl of PhiC31 integrase
transcribed from pCS2+ vector. After injections, embryos were incubated in
embryo water containing 0.1 g/l of Instant Ocean salts or E3 medium at 28-
29°C (Westerfield, 1993).
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Fluorescence reporter expression analysis
Transgenic embryos and larvae [60-96 hours post-fertilisation (hpf)] were
imaged using Olympus ScanR high content screening microscope
(Olympus) as described (Gehrig et al., 2009). Anaesthetised embryos were
oriented in an agarose template made with a brass mold (Peravali et al.,
2011). Stacks containing 100 slices of 4 μm thickness were taken, out of
focus slices were manually removed and maximum projections were made
using an extended depth of field plug-in for ImageJ software (Forster et al.,
2004). Expression domains were identified by comparing to anatomies and
gene expression data in ZFIN database (www.zfin.org). Statistical analysis
of variation of expression domains was carried out by binomial regression
using a generalised linear mixed-effects model.
Whole-mount in situ hybridisation
Whole-mount in situ hybridisation was carried out as previously described
(Thisse and Thisse, 2008). Digoxigenin (DIG)-labelled antisense probes
were produced by PCR using the following primers: Venus probe: F: 5′-
CAAGGGCGAGGAGCTGTT-3′ and R: 5′-AACTCCAGCAGGACCAT-
GT-3′; esrrga probe: F: 5′-CACTAACGGACAGCGTAAATCA-3′ and R:
5′-TCTCCAGCTTCATGCTCTTG-3′; GFP probe: F: 5′-ACACTTGT-
CACTACTTTCGC-3′ and R: 5′-AACTCAAGAAGGACCATGTG-3′.
Embryos were mounted in glycerol and imaged on an AxioScope
microscope (Carl Zeiss).
Analysis of shh enhancer activity in transient transgenic
embryos
The reporter constructs –2.4shh:attB:mCherry:ABC and –2.4shh:attB:ABC
were generated by replacing the GFP:poly(A) cassette from the
–2.4shh:gfp:ABC vector (Ertzer et al., 2007) with PCR-amplified
attB:mCherry:p(A) or attB cassettes from the pJET-attB-mCherry vector,
using XhoI/NotI restriction sites. About 2 nl of injection solution, containing
20 ng/μl reporter plasmid DNA, 15 ng/μl PhiC31nos mRNA and 0.1%
Phenol Red, was injected into zygotes of the landing lines. The injected
embryos were analysed for reporter expression by fluorescence microscopy
and whole-mount in situ hybridisation using GFP DIG-labelled probe at 48
hpf. The reporter-positive embryos identified by the in situ hybridisation
were categorised according to number and type of positive cells in relation
to the expected pattern of reporter construct activity.
Analysis of primordial germ cell (PGC) survival
PGC numbers were assessed at 24 hpf in embryos injected with PhiC31 and
PhiC31o-nos1-3′UTR mRNA (15 and 30 ng/μl, respectively) by anti-Vasa
antibody staining (kind gift from Holger Knaut, Skirball Institute, NY, USA)
as previously described (Nusslein-Volhard and Dahm, 2002). Antibodies
used were anti-Vasa (rabbit, 1:500) (Knaut et al., 2000) and secondary
antibody conjugated with HRP (goat, 1:150; A10260, Life Technologies).
Detection was carried out with DAB Peroxidase Substrate Kit (Vector
Laboratories) following the manufacturer’s instructions.
Molecular analysis of integration events
Genomic DNA was prepared from batches of lens GFP-positive and lens
GFP-negative embryos from an F1 or F2 outcross of Tg(pT2/Xla.crygc:attP-
GFP)tpl102, Tg(pT2/Xla.crygc:attP-GFP)tpl103, Tg(pT2/Xla.crygc:attP-
GFP)tpl104, and from an F3 outcross of Tg(Xla.crygc:attP-GFP)uobL6 and
Tg(Xla.crygc:attP-GFP)uobL12 lines. To map pT2/Xla.crygc:attP-GFP
integrations in lines tpl102, tpl103 and tpl104 integrations, genomic DNA
was digested in two separate reactions with TaqI, and a mix of
BamHI/BclI/BglII restriction enzymes. The digested DNA was ligated
overnight as described (Hermanson et al., 2004; Clark et al., 2011).
Amplification of genomic sequences flanking pT2/Xla.crygc:attP-GFP was
achieved by carrying two nested PCR reactions. For TaqI-digested DNA, the
5′ end of the construct was amplified using the primer pairs LP1 (5′-
GTGTCATGCACAAAGTAGATGTCC-3′) and GFPF3 (5′-TGAGTAAA -
GGAGAAGAACTTTTCAC-3′) in the first PCR reaction followed by the
second PCR reaction with LP2 (5′-ACTGACTTGCCAA AA -
CTATTGTTTG-3′) and GFPF1a (5′-TTCACTGGAGTTGTCCCA -
ATTCTTG-3′). Similarly, the 3′ end of the construct was amplified using
nRP1 (5′-CTAGGA TTAAAT GTCAGGAATTGTG-3′) and SBR1 (5′-
ACACTCAATTAGTA TTTGGTAGCAT-3′) primers in the first PCR, and
RP2 (5′-GTGAGTTTAAATGTATTTGGCTAAG-3′) and SBR2 (5′-
CATTG CCTTTAAATTGTTTAACTTG-3′) in the second PCR reaction. For
BamHI/BclI/BglII-digested DNA, the 5′ end of the construct was amplified
with LP1 (see above) and SBF1 (5′-AATTCCAGTGGGTCA -
GAAGTTTACA-3′), followed by second PCR with LP2 (see above) and
SBF2 (5′-GTTGACTGTGCCTTTAAACAGCTTG-3′) primers. The 3′ end
of the construct was isolated using nRP1 and GFPR1 (5′-
CAAGAGTGCCATGCCCGAA-3′) as well as RP2 (see above) and GFPR2
(5′-TTGCGAGATACCCAGATCATA-3′) in first and second PCRs,
respectively. To map Tg(Xla.crygc:attP-GFP)uobL6 and uobL12
integrations, genomic DNA was digested in three separate reactions: TaqI,
NlaIII, and BamHI/BclI/BglII. After ligation, inverse PCRs were carried out
to amplify the 3′ end of the construct only using the same primers for all
three differently digested genomic DNA sources: Tol2-R3 (5′-
ACTGGGCATCAGCGCAATTCAATTG-3′) and S1/3′ No1 (5′-GTTG -
TTAACTTGTTTATTGCAGCTT-3′), as well as Tol2-R4 (5′-ATAATACT -
TAAGTACAGTAATCAAG-3′) and S1/3′ No2 (5′-CAAACTCATCA -
ATGTATCTTATCAT-3′) in first and second PCRs, respectively. In addition
to the transposase-mediated integration recovered in Tg(Xla.crygc:attP-
GFP)uobL12, this line also has a non-transposase-mediated integration even
of pTol2/Xla.crygc:attP-GFP. Transgenic lines with integrase docking sites
will be made available from the zebrafish stock centres at the Zebrafish
International Resource Center (ZIRC) and the Karlsruhe Institute of
Technology (KIT) .
Southern blotting
DNA from GFP-positive and GFP-negative embryos from the five recipient
lines was digested with PvuII and PstI. Specificity and completeness of
digestions was verified by carrying out a parallel digestion with added
plasmid DNA. Digested DNA was separated on 1% agarose gel and
transferred to Whatman SPC Nytran membrane sheets (ThermoFisher
Scientific). The GFP probe was produced by carrying out a PCR using
primers GFP-F3 (5′-TGAGTAAAGGAGAAGAACTTTTCAC-3′) and
S1/3No2 (5′-CAAACTCATCAATGTATCTTATCAT-3′), then digesting the
PCR product with PstI and purifying it with ThermoFisher Fermentas Gel
Extraction Kit. The PCR fragment was then labelled using DECAPrimeII
DNA labelling kit (Ambion) and alphaP32 dCTP (Perkin Elmer) and
purified using Illustra ProbeQuant G-50 Micro Columns (GE Healthcare).
To analyse the copy number of the uobL12 transgenic recipient line, the
nylon membrane was exposed overnight, blocked by light for 30 minutes
and transferred to a Storage Phosphor Screen (Molecular Dynamics). It was
scanned on a Typhoon 9200 Variable Mode Imager (Amersham
Biosciences) with Typhoon Scanner Control software (v5.0) and analysed
using ImageQuant 5.1.
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